Equity Research firms currently have a positive stance on shares of NantHealth, Inc. (NASDAQ:NH). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.20. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $17.70 on a short term basis.
At the time of writing, the stock was trading at $13.19. This represents a change from the opening price of 1.23%. In terms of performance, year to date, the stock is -16.43%. The monthly stock performance comes in at 2.03%. For the quarter, shares are performing at -4.39%. Weekly performance analysis shows the equity at -2.61%.
In taking a look at technical levels, shares are trading 6.92% away from the 50 day simple moving average and 4.16% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -20.69% away from it’s 52- week high and 34.73% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, NantHealth, Inc.’s RSI stands at 53.27. In looking at volatility levels, the shares saw weekly volatility of 3.86% and 6.41% over the past month.